Status:
ACTIVE_NOT_RECRUITING
Electroencephalographic Biomarker to Predict Postoperative Delirium
Lead Sponsor:
University of Chile
Collaborating Sponsors:
Instituto Nacional del Cancer, Chile
Pontificia Universidad Catolica de Chile
Conditions:
Postoperative Delirium
Eligibility:
All Genders
60-100 years
Brief Summary
Acute post-operatory cognitive dysfunction states are one of the most important complications in older patients that underwent surgery. Among them postoperative delirium (POD) is the the most studied....
Detailed Description
Acute post-operatory cognitive dysfunction states are one of the most frequent complications in older patients after surgery, being POD the most important. Previous studies have shown than the inciden...
Eligibility Criteria
Inclusion
- Age ≥ 60 years old
- Scheduled for high-risk elective surgery
- Need for at least 3 days of hospital stay after surgery
- Surgery performed under general anesthesia
- Written informed consent for participation in the trial
Exclusion
- Patients with preoperative delirium or dementia
- Patients using neuroleptics drug during the past 6 months
- Patients with a history of encephalopathy, psychosis, stroke or brain trauma with neurologic sequels
- The use of ketamine or dexmedetomidine during surgery
- Emergency surgery
- Mechanical ventilation during the 72 after surgery
- Analphabetism
- Patients who do not talk Spanish
- Patients included in another clinical trial
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT05992506
Start Date
September 1 2023
End Date
June 30 2026
Last Update
November 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico Universidad de Chile
Santiago, Santiago Metropolitan, Chile, 8380456
2
Instituto Nacional del Cancer
Santiago, Santiago Metropolitan, Chile